Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China · Delayed Price · Currency is CNY 27.78
-0.80 (-2.80%)
Aug 10, 2026, 3:04 PM CST
SHE:002317 Market Cap
SHE:002317 has a market cap or net worth of 24.29 billion as of August 7, 2026. Its market cap has increased by 43.48% in one year.
Market Cap
24.29B
Enterprise Value
23.17B
Revenue
2.51B
Ranking
n/a
PE Ratio
81.66
Stock Price
27.78
ChartMarket Cap Chart
Since December 11, 2009, SHE:002317's market cap has increased from 7.22B to 24.29B, an increase of 236.66%. That is a compound annual growth rate of 7.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 24.29B | 50.58% |
| Dec 31, 2025 | 16.13B | 56.94% |
| Dec 31, 2024 | 10.28B | -24.46% |
| Dec 29, 2023 | 13.61B | -37.64% |
| Dec 30, 2022 | 21.82B | 126.34% |
| Dec 31, 2021 | 9.64B | 8.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apeloa Pharmaceutical Co.,Ltd | 26.36B |
| Zhejiang Huahai Pharmaceutical | 26.15B |
| Dizal (Jiangsu) Pharmaceutical | 26.05B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.91B |
| Livzon Pharmaceutical Group | 24.87B |
| Hubei Jumpcan Pharmaceutical | 23.87B |
| Tasly Pharmaceutical Group | 23.48B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.18B |